15291653

Source:http://linkedlifedata.com/resource/pubmed/id/15291653

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0043094, umls-concept:C0085228, umls-concept:C0311400, umls-concept:C2699787, umls-concept:C2825951
pubmed:issue	6
pubmed:dateCreated	2004-8-4
pubmed:abstractText	Adjunctive fluvoxamine inhibits clozapine metabolism and decreases plasma norclozapine (a toxic metabolite of clozapine) to clozapine ratios. This study aimed to demonstrate the effects of fluvoxamine on clozapine-related weight gain, hyperglycemia, and lipid abnormalities.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7801243
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antipsychotic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Clozapine, http://linkedlifedata.com/resource/pubmed/chemical/Fluvoxamine, http://linkedlifedata.com/resource/pubmed/chemical/Serotonin Uptake Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides, http://linkedlifedata.com/resource/pubmed/chemical/norclozapine
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	0160-6689
pubmed:author	pubmed-author:ChangWen-HoWH, pubmed-author:ChenKun-PoKP, pubmed-author:LaneHsien-YuanHY, pubmed-author:LinShih-KuSK, pubmed-author:LuMong-LiangML
pubmed:issnType	Print
pubmed:volume	65
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	766-71
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:15291653-Adolescent, pubmed-meshheading:15291653-Adult, pubmed-meshheading:15291653-Antipsychotic Agents, pubmed-meshheading:15291653-Blood Glucose, pubmed-meshheading:15291653-Cholesterol, pubmed-meshheading:15291653-Clozapine, pubmed-meshheading:15291653-Drug Interactions, pubmed-meshheading:15291653-Drug Monitoring, pubmed-meshheading:15291653-Drug Therapy, Combination, pubmed-meshheading:15291653-Female, pubmed-meshheading:15291653-Fluvoxamine, pubmed-meshheading:15291653-Humans, pubmed-meshheading:15291653-Hyperglycemia, pubmed-meshheading:15291653-Hyperlipidemias, pubmed-meshheading:15291653-Male, pubmed-meshheading:15291653-Middle Aged, pubmed-meshheading:15291653-Serotonin Uptake Inhibitors, pubmed-meshheading:15291653-Triglycerides, pubmed-meshheading:15291653-Weight Gain
pubmed:year	2004
pubmed:articleTitle	Adjunctive fluvoxamine inhibits clozapine-related weight gain and metabolic disturbances.
pubmed:affiliation	Department of Psychiatry, Taipei Medical University-Wan Fang Hospital, Taiwan.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't